# 2021 Summer's Way Rhabdomyosarcoma Workshop. Bringing researchers, clinicians, industry scientists, families, and foundations together to collaboratively advace RMS research and therapeutics.

> **NIH NIH R13** · SUMMER'S WAY FOUNDATION · 2021 · $5,000

## Abstract

Project Summary Abstract/2021 Summer’s Way Rhabdomyosarcoma Workshop
Rhabdomyosarcoma (RMS) is a rare childhood cancer associated with a high mortality rate. Treatment options
are limited, with no substantial breakthrough in over 30 years. The Summer’s Way Foundation has taken the
lead in coalescing the RMS community through these unique and diverse workshops. They have become the
premiere venue towards advancing our understanding of the biology of this tumor, developing targeted
therapy, and creating collaborative research groups. with a diversity of scientist/clinicians both international
and within the United States through gender, ethnicity, race, and leadership while capturing researchers at
various stages in their career. Families and patients impacted by RMS as well as foundations supporting RMS
are an integral part of the workshop and 2021 will add the pharmaceutical industry to our table as stakeholders
in our community.
Our two day interactive format will feature topics on translational basic science, pre-clinical modeling, clinical
trials, immunotherapy, emerging technologies with a unique family advocacy session. This novel workshop
model has become the RMS community’s pathway towards finally achieving significant therapeutic advances,
in what has been a devastating and neglected childhood cancer.

## Key facts

- **NIH application ID:** 10236831
- **Project number:** 1R13CA261082-01
- **Recipient organization:** SUMMER'S WAY FOUNDATION
- **Principal Investigator:** Sharon Lucille Hammond
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $5,000
- **Award type:** 1
- **Project period:** 2021-06-01 → 2022-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10236831

## Citation

> US National Institutes of Health, RePORTER application 10236831, 2021 Summer's Way Rhabdomyosarcoma Workshop. Bringing researchers, clinicians, industry scientists, families, and foundations together to collaboratively advace RMS research and therapeutics. (1R13CA261082-01). Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/grant/nih/10236831. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*